{"id":"W1974202914","doi":"10.2174/138161212799315975","title":"New Developments in Inhaled Antibiotics for the Treatment of Pseudomonas aeruginosa","year":2012,"lang":"en","type":"review","venue":"Current Pharmaceutical Design","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Cystic fibrosis; Tobramycin; Pseudomonas aeruginosa; Antibiotics; Nebulizer; Medicine; Aerosolization; Pneumonia; Intensive care medicine; Lung disease; Lung; Inhalation; Microbiology; Bacteria; Internal medicine; Biology; Gentamicin; Anesthesia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005289588,0.0005365104,0.001836624,0.000267098,0.00005521654,0.0000219345,0.0003120885,0.0001753492,0.0001171694],"category_scores_gemma":[0.0002909731,0.0003071901,0.0005008226,0.0005288656,0.0001638065,0.00006250266,0.00006193618,0.0004108277,0.00007745279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000560673,"about_ca_system_score_gemma":0.001343352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002915027,"about_ca_topic_score_gemma":6.341269e-7,"domain_scores_codex":[0.9970033,0.0002590851,0.000962901,0.0004413497,0.0005452579,0.0007880825],"domain_scores_gemma":[0.9957809,0.002966334,0.0002276788,0.0004111696,0.0001024242,0.0005115242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002636928,0.0009916349,0.00003652848,0.01441638,0.0003145034,0.00001445054,0.000057343,0.000001086639,0.0000166722,0.000129643,0.0006271995,0.9831309],"study_design_scores_gemma":[0.002587633,0.000466253,0.00003479411,0.007241873,0.002440665,0.00005528425,0.000004464299,0.0001441983,0.0005882838,0.00001912942,0.9861596,0.0002578392],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000002726651,0.9705595,0.02191042,0.00005718664,0.0007607107,0.006586398,0.00005976505,0.00002458628,0.0000387321],"genre_scores_gemma":[0.0001059062,0.9835485,0.01542652,0.000009046264,0.0004137871,0.0001310691,0.0001102447,0.00006213575,0.0001927631],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9855324,"threshold_uncertainty_score":0.999938,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3737254702533679,"score_gpt":0.5102760430366514,"score_spread":0.1365505727832835,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}